Technical Analysis for OMGA - Omega Therapeutics, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 2.15 | -0.46% | -0.01 |
OMGA closed down 0.46 percent on Wednesday, May 8, 2024, on 1.41 times normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Hammer Candlestick | Bullish | 0.00% | |
Lizard Bullish | Bullish Day Trade Setup | 0.00% | |
Doji - Bullish? | Reversal | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Stochastic Reached Oversold | Weakness | -0.46% | |
Wide Bands | Range Expansion | -0.46% |
Alert | Time |
---|---|
2x Volume Pace | about 15 hours ago |
1.5x Volume Pace | about 15 hours ago |
Down 5% | about 15 hours ago |
Fell Below Lower Bollinger Band | about 15 hours ago |
Lower Bollinger Band Support | about 15 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2024
Omega Therapeutics, Inc., a biotechnology company, develops genomic medicines to cure diseases. The company focuses on precision tuning to activate the human genome's native capacity to treat and cure diseases. It engages in designing, engineering, and manufacturing Epigenomic Controllers to target the GenomStats for the cell types of interest, with the ability to downregulate or upregulate genomic activity for therapeutic effect. Omega Therapeutics, Inc. was formerly known as VL42, Inc. and changed its name to Omega Therapeutics, Inc. in July 2017. The company was incorporated in 2016 and is based in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Disease Human Genome
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Disease Human Genome
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 10.08 |
52 Week Low | 1.3 |
Average Volume | 347,810 |
200-Day Moving Average | 3.06 |
50-Day Moving Average | 3.12 |
20-Day Moving Average | 2.43 |
10-Day Moving Average | 2.35 |
Average True Range | 0.24 |
RSI (14) | 35.48 |
ADX | 25.06 |
+DI | 21.38 |
-DI | 33.08 |
Chandelier Exit (Long, 3 ATRs) | 2.45 |
Chandelier Exit (Short, 3 ATRs) | 2.67 |
Upper Bollinger Bands | 2.82 |
Lower Bollinger Band | 2.03 |
Percent B (%b) | 0.15 |
BandWidth | 32.75 |
MACD Line | -0.22 |
MACD Signal Line | -0.24 |
MACD Histogram | 0.0198 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.45 | ||||
Resistance 3 (R3) | 2.42 | 2.29 | 2.40 | ||
Resistance 2 (R2) | 2.29 | 2.21 | 2.30 | 2.38 | |
Resistance 1 (R1) | 2.22 | 2.16 | 2.15 | 2.25 | 2.36 |
Pivot Point | 2.09 | 2.09 | 2.06 | 2.10 | 2.09 |
Support 1 (S1) | 2.02 | 2.01 | 1.95 | 2.05 | 1.93 |
Support 2 (S2) | 1.89 | 1.96 | 1.90 | 1.91 | |
Support 3 (S3) | 1.82 | 1.89 | 1.90 | ||
Support 4 (S4) | 1.85 |